Superpower Health

Informed Medical Consent for Pregnyl (hCG)

Last Updated and Effective:
2.28.2025

INTRODUCTION

THIS INFORMED CONSENT (THE “CONSENT”) FOR HCG (PREGNYL) SETSFORTH THE TERMS AND POLICIES FOR THE CLINICAL SERVICES PROVIDED BY SUPERPOWERMEDICAL GROUP OF CA PC, A CALIFORNIA PROFESSIONAL MEDICAL CORPORATION, ANDOTHER THIRD-PARTY MEDICAL GROUPS (COLLECTIVELY, THE “MEDICAL GROUPS”) THROUGHTHE ONLINE TECHNOLOGY PLATFORM (“PLATFORM” OR “SUPERPOWER PLATFORM”), WHICH ISOWNED AND OPERATED BY SUPERPOWER HEALTH, INC. (“SUPERPOWER”).

The purpose of this consent is to provide you withinformation about the risks, benefits, and safety considerations associatedwith hCG (brand name: Pregnyl) in order for you to make an informed decision asto whether or not to proceed with treatment, as well as to obtain youragreement to adhere to the treatment protocol as prescribed by your MedicalGroup healthcare provider (“Healthcare Provider”). Please read this formcarefully and ask any questions you have before signing.

GENERAL INFORMATION

Human Chorionic Gonadotropin (hCG) is a hormoneproduced in the placenta during pregnancy. Commercially produced hCG (e.g.,Pregnyl) is FDA-approved for certain indications, such as fertility treatments,by helping stimulate ovulation in females and supporting testicular function inmales. hCG may also be prescribed off-label for other conditions as determinedby your Healthcare Provider.

  • FDA     Status: Pregnyl (hCG) is FDA-approved for specific medical uses     (e.g., treatment of infertility, hypogonadism). If you are prescribed hCG     for any purpose not explicitly approved by the FDA, you should be aware     that such use is considered off-label.
  • Mechanism     of Action:
       
    • In      females, hCG can mimic luteinizing hormone (LH), helping trigger      ovulation and support the corpus luteum.
    •  
    • In      males, hCG can help maintain or boost testosterone production by acting      on the Leydig cells of the testes.
    •  
    • Off-label      uses include certain endocrine or metabolic protocols, the effectiveness      and safety of which may not be established by the FDA.

As with any therapy, there are potential benefits andrisks.

POTENTIAL BENEFITS OF hCG

  • Fertility     Support: Can help induce or regulate ovulation in females and support     sperm production in males.
  • Hormone     Regulation: May help increase testosterone levels in males with     certain forms of hypogonadism.
  • Off-Label     Applications: Potential improvements in certain metabolic or weight     management programs, although scientific evidence varies, and these     indications are not FDA-approved.

Individual results will vary, and effectiveness dependson your overall health and adherence to the prescribed protocol.

POTENTIAL SIDE EFFECTS OF hCG

Possible side effects include, but are not limited to:

  1. Injection     Site Reactions: Pain, redness, swelling, or bruising at the injection     site.
  2. Hormonal     Fluctuations: Headaches, mood changes, irritability, fatigue, or     restlessness.
  3. Ovarian     Hyperstimulation Syndrome (OHSS): In females undergoing fertility     treatment, there is a risk of OHSS, which may cause enlarged ovaries,     abdominal pain, and other complications.
  4. Gynecomastia     (Males): Enlargement or tenderness of breast tissue.
  5. Allergic     Reactions: Rare but may include rash, itching, swelling, dizziness, or     difficulty breathing.

This is not an exhaustive list. If you experience anysevere or persistent side effects, notify your Healthcare Provider immediately.

TREATMENT PROTOCOL

Your Healthcare Provider will determine the specific dosage,timing, and route of administration based on your medical history, currenthealth status, and treatment goals. hCG (Pregnyl) is typically administered viasubcutaneous or intramuscular injection.

Standard Usage Instructions

  1. Dosage     & Frequency: Follow your Healthcare Provider’s prescription     exactly. Do not alter your dosage unless instructed.
  2. Injection     Technique: Your Healthcare Provider may instruct you on self-injection     techniques, including proper needle handling and disposal.
  3. Monitoring:     Regular follow-up may be required. This may include blood tests,     ultrasounds (for fertility protocols), or other evaluations to monitor     your body’s response.

Adherence

It is critical to follow your prescribed treatment plan andto communicate any new or worsening symptoms to your Healthcare Providerpromptly.

ALTERNATIVES TO hCG

Depending on your condition or treatment goals, alternativesto hCG may include:

  • Other     Fertility Treatments: Medications such as clomiphene citrate,     letrozole, or assisted reproductive technologies (e.g., IVF).
  • Hormone     Replacement Therapies: Testosterone therapy or other approved     medications, as indicated.
  • Lifestyle     Interventions: Diet, exercise, weight management, and stress     reduction, which can influence hormone levels and overall health.

These alternatives may or may not provide the same benefitsas hCG therapy and should be discussed with your Healthcare Provider.

CONTRAINDICATIONS

You should not use hCG if:

  • You     have a known allergy or hypersensitivity to hCG or any of its components.
  • You     have certain hormone-sensitive tumors (e.g., prostate cancer, some breast     cancers) or undiagnosed uterine bleeding.
  • You     are pregnant, intending to become pregnant (outside of prescribed     fertility protocols), or breastfeeding without consulting your Healthcare     Provider.
  • Your     Healthcare Provider deems it clinically inappropriate based on your     medical history or current condition.

ADDITIONAL SAFETY INFORMATION

  • Medication     & Supplement Disclosure: Inform your Healthcare Provider of all     prescription drugs, over-the-counter medications, and supplements you are     taking to avoid potential interactions.
  • Storage     & Handling: If self-injecting, store hCG (Pregnyl) as instructed     (e.g., in a refrigerator if required) and follow all guidelines for safe     handling and needle disposal.
  • Monitor     for Adverse Events: Contact your Healthcare Provider immediately if     you experience unusual or severe side effects, signs of allergic     reactions, or other concerning symptoms.

USE OF TELEHEALTH

Your Clinical Services may be provided via telehealth.Telehealth involves the use of electronic communication for diagnosis,treatment, and follow-up care. By agreeing to this Consent, you acknowledge thefollowing:

  • Telehealth     offers improved access to care but may limit the ability to perform a full     physical examination.
  • Potential     risks include delays due to technical issues and rare breaches of data     security.
  • You     must be physically located in the state where your Healthcare Provider is     licensed during telehealth visits, unless otherwise permitted by law.

INFORMED CONSENT & ADHERENCE TO TREATMENT PLAN

By signing this informed consent, you acknowledge that you:

  1. Have     read and understood the information provided about hCG (Pregnyl),     including its risks, benefits, and safety considerations. You understand     that hCG is FDA-approved for certain uses and may be prescribed off-label,     for which safety and efficacy may not be fully established.
  2. Agree     to adhere to the treatment protocol as prescribed by your Healthcare     Provider and report any severe side effects or concerns promptly.
  3. Understand     that there are no guarantees or assurances regarding treatment     outcomes.
  4. Certify     that you have disclosed all relevant health information, including     allergies, medications, and medical history, to your Superpower Healthcare     Providers.

CERTIFICATION OF CONSENT

By clicking “I AGREE” or signing below, you certify that:

  • You     have read and understood this entire Informed Consent.
  • You     have had the opportunity to ask questions, and all your questions have     been answered to your satisfaction.
  • You     freely and voluntarily accept all risks associated with hCG (Pregnyl)     therapy and consent to proceed with treatment.

MEMBER NAME: ___________________________
SIGNATURE: ______________________________
DATE: ____________________________________